COM:ELEVATIONONCOLOGY
Elevation Oncology, Inc.
- Stock
Last Close
0.69
13/11 21:00
Market Cap
144.25M
Beta: -
Volume Today
769.22K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '20 | Jun '20 | Sep '20 | Dec '20 | Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | Sep '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cost and expenses | 1.96M - | 3.42M 74.48% | 3.01M 11.88% | 8.89M 195.05% | 5.09M 42.77% | 5.06M 0.53% | 12.28M 142.68% | 9.62M 21.61% | 17.37M 80.47% | 20.11M 15.80% | 38.53M 91.57% | 18.54M 51.89% | 11.64M 37.22% | 9.83M 15.50% | 10.92M 11.04% | 7.95M 27.23% | 9.87M 24.20% | 10.96M 11.09% | 13.23M 20.67% | |
cost of revenue | 10K - | |||||||||||||||||||
depreciation and amortization | 15K - | 4K 73.33% | 6K 50% | 3K 50% | 5K 66.67% | 4K 20% | 5K 25% | 8K 60% | 10K 25% | 10.22M 102,140% | 10K 99.90% | 9K 10% | 10K 11.11% | |||||||
ebitda | -1.96M - | -3.42M 74.48% | -3.01M 11.88% | -8.87M 194.56% | -5.08M 42.72% | -5.05M 0.57% | -12.27M 142.91% | -9.62M 21.63% | -17.36M 80.52% | -20.11M 15.80% | -38.52M 91.58% | -18.54M 51.88% | -6.52M 64.82% | -9.82M 50.65% | -10.92M 11.16% | -7.94M 27.33% | -9.87M 24.36% | -10.96M 11.09% | -13.23M 20.67% | |
eps | -0.12 - | -0.21 75% | -0.18 14.29% | -0.54 200.00% | -0.22 59.26% | -4.84 2,100% | -0.53 89.05% | -0.79 49.06% | -0.74 6.33% | -0.85 14.86% | -1.68 97.65% | -0.82 51.19% | -0.72 12.20% | -0.37 48.61% | -0.25 32.43% | -0.19 24% | -0.00 99.89% | -0.00 0% | -0.00 0% | |
eps diluted | -0.12 - | -0.21 75% | -0.18 14.29% | -0.54 200.00% | -0.22 59.26% | -4.84 2,100% | -0.53 89.05% | -0.79 49.06% | -0.74 6.33% | -0.85 14.86% | -1.68 97.65% | -0.82 51.19% | -0.72 12.20% | -0.37 48.61% | -0.25 32.43% | -0.19 24% | -0.00 99.89% | -0.00 0% | -0.00 0% | |
general and administrative expenses | 471K - | 414K 12.10% | 462K 11.59% | 453K 1.95% | 952K 110.15% | 1.15M 20.27% | 2.98M 160.17% | 3.38M 13.29% | 3.79M 12.39% | 3.81M 0.53% | 4.19M 9.91% | 4.04M 3.72% | 4.35M 7.71% | 3.81M 12.45% | 3.50M 8.07% | 3.25M 6.95% | 3.86M 18.53% | 4.41M 14.36% | 3.84M 12.94% | |
gross profit | -10K - | |||||||||||||||||||
income before tax | -1.96M - | -3.41M 73.95% | -3.01M 11.60% | -8.89M 195.25% | -5.09M 42.73% | -5.06M 0.63% | -12.27M 142.48% | -9.62M 21.56% | -17.27M 79.54% | -19.93M 15.35% | -38.84M 94.91% | -19.02M 51.03% | -17.05M 10.32% | -10.11M 40.75% | -10.63M 5.15% | -7.89M 25.74% | -10.70M 35.56% | -10.45M 2.30% | -12.87M 23.15% | |
income tax expense | -93K - | -187K 101.08% | 306K 263.64% | 25K 91.83% | 5K 80% | 5K 0% | 11K 120% | 9K 18.18% | 11K 22.22% | 11K 0% | 12K 9.09% | |||||||||
interest expense | -93K - | -187K 101.08% | 306K 263.64% | 470K 53.59% | 309K 34.26% | 4.17M - | 115K 97.24% | 513K 346.09% | 360K 29.82% | |||||||||||
interest income | 3.90M - | |||||||||||||||||||
net income | -1.96M - | -3.41M 73.95% | -3.01M 11.60% | -8.89M 195.25% | -5.09M 42.73% | -5.06M 0.63% | -12.27M 142.48% | -9.62M 21.56% | -17.18M 78.57% | -19.74M 14.88% | -39.14M 98.30% | -19.04M 51.35% | -17.06M 10.41% | -10.11M 40.74% | -10.64M 5.20% | -7.90M 25.73% | -10.71M 35.55% | -10.46M 2.30% | -12.88M 23.13% | |
operating expenses | 1.96M - | 3.42M 74.48% | 3.01M 11.88% | 8.89M 195.05% | 5.09M 42.77% | 5.06M 0.53% | 12.28M 142.68% | 9.62M 21.61% | 17.37M 80.47% | 20.11M 15.80% | 38.53M 91.57% | 18.54M 51.89% | 11.64M 37.22% | 9.83M 15.50% | 10.92M 11.04% | 7.94M 27.33% | 9.87M 24.36% | 10.96M 11.09% | 13.23M 20.67% | |
operating income | -1.96M - | -3.42M 74.48% | -3.01M 11.88% | -8.89M 195.05% | -5.09M 42.77% | -5.06M 0.53% | -12.28M 142.68% | -9.62M 21.61% | -17.37M 80.47% | -20.11M 15.80% | -38.53M 91.57% | -18.54M 51.89% | -16.75M 9.67% | -9.83M 41.27% | -10.92M 11.04% | -7.95M 27.23% | -9.87M 24.20% | -10.96M 11.09% | -13.23M 20.67% | |
other expenses | 1K - | 12K 1,100% | 1K 91.67% | -3K 400% | -5K 66.67% | 10K - | 2K 80% | 93K 4,550% | 187K 101.08% | -306K 263.64% | -480K 56.86% | -309K 35.63% | -271K 12.30% | 295K 208.86% | 56K 81.02% | |||||
research and development expenses | 1.49M - | 3.00M 101.88% | 2.55M 15.11% | 8.43M 230.75% | 4.13M 50.98% | 3.91M 5.32% | 9.30M 137.56% | 6.25M 32.79% | 13.57M 117.23% | 16.30M 20.07% | 34.34M 110.67% | 14.50M 57.77% | 7.29M 49.72% | 6.03M 17.32% | 7.42M 23.10% | 4.69M 36.80% | 6.01M 28.14% | 6.55M 8.98% | 9.39M 43.31% | |
revenue | ||||||||||||||||||||
selling and marketing expenses | -10K - | |||||||||||||||||||
selling general and administrative expenses | 471K - | 414K 12.10% | 462K 11.59% | 453K 1.95% | 952K 110.15% | 1.15M 20.27% | 2.98M 160.17% | 3.38M 13.29% | 3.79M 12.39% | 3.81M 0.53% | 4.19M 9.91% | 4.04M 3.72% | 4.35M 7.71% | 3.81M 12.45% | 3.50M 8.07% | 3.25M 7.23% | 3.86M 18.89% | 4.41M 14.36% | 3.84M 12.94% | |
total other income expenses net | 1K - | 12K 1,100% | 1K 91.67% | -3K 400% | -5K 66.67% | 10K - | 2K 80% | 93K 4,550% | 187K 101.08% | -306K 263.64% | -480K 56.86% | -309K 35.63% | -271K 12.30% | 295K 208.86% | 56K 81.02% | -827K 1,576.79% | 513K 162.03% | 360K 29.82% | ||
weighted average shs out | 16.54M - | 16.54M 0% | 16.54M 0% | 16.54M 0% | 22.82M 38.01% | 1.05M 95.42% | 23.11M 2,109.34% | 12.13M 47.51% | 23.22M 91.35% | 23.26M 0.18% | 23.29M 0.14% | 23.30M 0.05% | 23.62M 1.36% | 27.58M 16.75% | 42.40M 53.77% | 42.42M 0.03% | 47.37B 111,583.96% | 59.02B 24.59% | 59.11B 0.15% | |
weighted average shs out dil | 16.54M - | 16.54M 0% | 16.54M 0% | 16.54M 0% | 22.82M 38.01% | 1.05M 95.42% | 23.11M 2,109.34% | 12.13M 47.51% | 23.22M 91.35% | 23.26M 0.18% | 23.29M 0.14% | 23.30M 0.05% | 23.62M 1.36% | 27.58M 16.75% | 42.40M 53.77% | 42.42M 0.03% | 47.37B 111,583.96% | 59.02B 24.59% | 59.11B 0.15% |
All numbers in (except ratios and percentages)